Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy

The Motley Fool | Sep 30, 2026 7:30 PM EDT

Key PointsNovo Nordisk could strengthen its obesity pipeline by buying out Kailera Therapeutics and Viking Therapeutics.